Minerva Neurosciences Inc (NERV) — Cash Flow Reinvestment Rate

Latest as of September 2017: 3.21x

Minerva Neurosciences Inc (NERV) has a Cash Flow Reinvestment Rate of 3.21x as of September 2017, reinvesting $79.80 Million (capex $0.00 plus investments $-79.80 Million) from operating cash flow of $24.89 Million. Check NERV operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

3.21x
(Capex + Investments) / Operating CF

Total Reinvested

$79.80 Million
Capex + Investments

Operating Cash Flow

$24.89 Million
USD

Capital Expenditures

$0.00
USD

Minerva Neurosciences Inc Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for Minerva Neurosciences Inc across 1 annual periods. Explore Minerva Neurosciences Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Minerva Neurosciences Inc (2017–2017)

Year-by-year capital reinvestment analysis for Minerva Neurosciences Inc. For live market cap and broader valuation context, see NERV company net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2017 34.66x $107.19 Million $3.09 Million $52.40K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow